<- Back to Insights
March 9, 2024
Mark Cuban's drug company partners with 1st health system
Becker's Hospital Review
|
Summary
On March 7, Community Health Systems (CHS), based in Franklin, Tennessee, became the inaugural hospital system to form a partnership with and procure medications from Mark Cuban Cost Plus Drug Co., marking a significant step in addressing drug supply challenges and the escalating costs of pharmaceuticals. This collaboration aims to tackle issues such as pharmaceutical waste, drug shortages, and enhancing patient safety and medication error prevention by leveraging flexible drug ordering options, including offering medications in alternative vial sizes to minimize waste and dosage errors. Furthermore, Cost Plus Drugs is set to commence the production of epinephrine and norepinephrine in its new $11 million drug manufacturing facility in Dallas, with plans to extend its manufacturing to injectable drugs in shortage and pediatric oncology solutions. This partnership aligns with Cost Plus Drugs' ongoing efforts to integrate into the health system industry, offering a marketplace for essential medicines to hospitals, ASCs, clinics, and other healthcare facilities.
![]()
Explore Related Topics
